Start the conversation
Comment on This Story
Or to contact Money Morning Customer Service, click here.
After perusing all the displays at the massive Consumer Electronics Show in Las Vegas earlier this month, tech-sector pundits began touting ultra-high-definition television (UHDTV) as one of the next big "breakout" technologies for 2014.
This wasn't a surprise to you.
Back in August, we said that specialty microchip maker Ambarella Inc. (Nasdaq: AMBA) would be a major beneficiary of the UHDTV surge and predicted the stock could double in just over two years.
It actually took only five months, and we now believe it will double again.
But we also know this isn't the only company benefitting from the powerful shift toward the new UHDTV standard – and so we set out to find the "next Ambarella."
Last week, we found it.
The stock we discovered is about to be ignited by two powerful catalysts – the multi-billion-dollar shift to UHDTV and a shrewd strategic shift that's going to twist open the profit spigot.
It's a stock we believe could easily double from here, making it one of the best tech stocks to buy in 2014.
And today we're going to show you all that you need to know to pocket every penny of those gains…
Tech Stocks to Buy: A Highly Defined Profit Opportunity
The shift from the current HDTV standard to the new UHDTV opportunity is one of the most exciting things to hit television in years.
This technology also is known as "4K" because these new, sharper-definition TV sets display 4,000 horizontal lines of video, making them roughly four times sharper than the images displayed on current HDTVs.
The Consumer Electronics Association – the trade group that runs CES – predicted that just 23,000 UHDTVs would be sold in the U.S. market in 2013. But that figure will soar to 1.43 million sets, or roughly 5% of TVs sold nationally, by the end of 2016 – a 60-fold increase.
NPD DisplaySearch has an even more aggressive outlook and sees nearly a sevenfold increase next year alone. NPD estimates that sales came in at 1.9 million for 2013 and predicts that sales will rise to 12.7 million in 2014.
And by 2017, UHDTVs will account for nearly one-fourth of all televisions of greater than 50 inches sold in the U.S. market, NPD projects.
But there's a problem.
About the Author
Michael A. Robinson is a 36-year Silicon Valley veteran and one of the top tech and biotech financial analysts working today. That's because, as a consultant, senior adviser, and board member for Silicon Valley venture capital firms, Michael enjoys privileged access to pioneering CEOs, scientists, and high-profile players. And he brings this entire world of Silicon Valley "insiders" right to you...
- He was one of five people involved in early meetings for the $160 billion "cloud" computing phenomenon.
- He was there as Lee Iacocca and Roger Smith, the CEOs of Chrysler and GM, led the robotics revolution that saved the U.S. automotive industry.
- As cyber-security was becoming a focus of national security, Michael was with Dave DeWalt, the CEO of McAfee, right before Intel acquired his company for $7.8 billion.
This all means the entire world is constantly seeking Michael's insight.
In addition to being a regular guest and panelist on CNBC and Fox Business, he is also a Pulitzer Prize-nominated writer and reporter. His first book Overdrawn: The Bailout of American Savings warned people about the coming financial collapse - years before the word "bailout" became a household word.
Silicon Valley defense publications vie for his analysis. He's worked for Defense Media Network and Signal Magazine, as well as The New York Times, American Enterprise, and The Wall Street Journal.
And even with decades of experience, Michael believes there has never been a moment in time quite like this.
Right now, medical breakthroughs that once took years to develop are moving at a record speed. And that means we are going to see highly lucrative biotech investment opportunities come in fast and furious.
To help you navigate the historic opportunity in biotech, Michael launched the Bio-Tech Profit Alliance.
His other publications include: Strategic Tech Investor, The Nova-X Report, Bio-Technology Profit Alliance and Nexus-9 Network.
What happened to STM? I have seen this same question asked time and time again.